Canton Strategic Holdings (CNTN) Total Current Liabilities (2020 - 2026)
Canton Strategic Holdings (CNTN) reported Total Current Liabilities of $1.1 million for Q1 2026, down 53.9% on a YoY basis from $2.5 million in Q1 2025, and down 65.27% quarter-over-quarter from $3.3 million in Q4 2025.
Canton Strategic Holdings (CNTN) Total Current Liabilities (2020 - 2026) Analysis & Trends
Canton Strategic Holdings has reported Total Current Liabilities for 7 years, with the latest figure at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities fell 53.9% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (down 53.9% YoY), and the FY2025 full-year result was $3.3 million, up 36.14% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $1.1 million, down from $3.3 million in the prior quarter.
- The five-year high for Total Current Liabilities was $3.3 million in Q4 2025, with the low at $902348.0 in Q3 2022.
- Historically, Total Current Liabilities has averaged $1.8 million across 5 years, with a median of $1.6 million in 2024.
- Annual changes were most pronounced in 2022 — Total Current Liabilities slumped 74.75% — and 2023, when it soared 58.52%.
- Canton Strategic Holdings' Total Current Liabilities stood at $1.1 million in 2022, then soared by 58.52% to $1.8 million in 2023, then surged by 33.0% to $2.4 million in 2024, then soared by 36.14% to $3.3 million in 2025, then plunged by 65.27% to $1.1 million in 2026.
- The last three Total Current Liabilities figures came in at $1.1 million (Q1 2026), $3.3 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | 1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 3.29 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 2.16 Mn |
| Mar 31, 2025 | 2.48 Mn |
| Dec 31, 2024 | 2.41 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 1.84 Mn |
| Dec 31, 2023 | 1.82 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 902,348.00 |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 4.53 Mn |
| Dec 31, 2020 | 2.73 Mn |